Navigation Links
PhRMA Applauds House Committee on Foreign Affairs Commitment to Continuing Efforts to Fight AIDS, Tuberculosis, and Malaria Epidemics
Date:2/29/2008

WASHINGTON, Feb. 28 /PRNewswire-USNewswire/ -- Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin today released the following statement on the passage of the Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis and Malaria Reauthorization Act (H.R. 5501) by the United States House Committee on Foreign Affairs:

"America's pharmaceutical research companies commend the House Committee on Foreign Affairs for passing the Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis and Malaria Reauthorization Act (H.R. 5501). This admirable bipartisan bill will allow for the continuation of the unprecedented programs and partnerships implemented by the President's Emergency Plan for AIDS Relief (PEPFAR), the President's Malaria Initiative (PMI) and other global health programs.

"We are committed to fighting the global HIV, TB and malaria epidemics and we look forward to continuing to work with the partnerships created by PEPFAR and PMI to find new, innovative solutions to fight these diseases.

"The reauthorization of these initiatives is a groundbreaking step in worldwide efforts. Already, PEPFAR has provided care or treatment for over 6.6 million people infected or affected by HIV/AIDS, including 2.7 million orphans and vulnerable children.

"This bill provides much needed resources to halt the 6,000 new HIV infections that occur every day and the approximately 6 million deaths from HIV, TB and malaria that occur every year, primarily in Africa.

"This bill and the promise it holds for curbing the AIDS, TB and malaria epidemics is a great tribute to the inspirational leadership of the late former chairmen of the Committee, Rep. Tom Lantos and Rep. Henry J. Hyde."

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country's leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $43 billion in 2006 in discovering and developing new medicines. Industry-wide research and investment reached a record $55.2 billion in 2006.

PhRMA Internet Address: http://www.phrma.org

For information on stories of hope and survival, visit: http://sharingmiracles.com/

For information on how innovative medicines save lives, visit: http://www.innovation.org

For information on the Partnership for Prescription Assistance, visit: http://www.pparx.org

For information on the danger of imported drugs, visit: http://www.buysafedrugs.info


'/>"/>
SOURCE Pharmaceutical Research and Manufacturers of America(PhRMA)
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. PhRMA Celebrates 20th Anniversary of Discoverers Award
2. PhRMA Statement on Enactment of FDA Legislation
3. AGA Institute applauds delay of Aetna sedation restrictions
4. TFAH Applauds Release of CDCs State-Specific Public Health Emergency Preparedness Report
5. OrthoSynetics(TM) Applauds SEC Suit Against Former Company Management
6. Psoriasis Cure Now Applauds Record Government Psoriasis Research Funding
7. PCMA Applauds Secretary Leavitts Support for Requiring E-Prescribing in Medicare
8. Training Magazine Applauds Aflacs Employee Learning Programs
9. MedeFile Applauds U.S. Presidential Hopefuls for Advocating Widespread Adoption of Electronic Medical Records
10. Blunt Applauds Passage of Republican-Crafted SCHIP Extension
11. IOF applauds NOS on NICE Guidance appeal success and urges continued efforts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... ... May 05, 2016 , ... ... enrichment program serving families of greater Dubuque, IA. The current campaign fundraises for ... honorably discharged veterans. Donations to Veteran’s Freedom Center may now be made here: ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... focused resources for veterinary professionals across the United States. The whole food nutrient ... of their patients and giving dog, cat and horse owners’ peace of mind. ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... presented a talk highlighting the organization’s successful Care Transitions program at ... The talk was titled “Minimizing Costs in the Post-Acute Environment Through Effective Transitions ...
(Date:5/5/2016)... CA (PRWEB) , ... May 05, 2016 , ... In ... nursing firm, is encouraging people all over the United States to thank a nurse ... 12, Aya Healthcare will donate $5 to the American Red Cross of San Diego/Imperial ...
(Date:5/5/2016)... ... May 05, 2016 , ... United Collection Bureau, Inc. (UCB) announces Sarah ... than 15 years of experience within the healthcare revenue cycle industry. With a primary ... Director of Patient Financial Services at Spectrum Health. While at Spectrum Health, Clark helped ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... New York , May 4, 2016 ... by Transparency Market Research entitled "Brain Computer Interface Market - ... 2016 - 2024," the  global brain computer interface (BCI) market ... by 2024. The market is estimated to expand at ... from 2016 to 2024. A BCI device ...
(Date:5/4/2016)... May 4, 2016 In ... a series of free workshops across ... requirements for Good Distribution Practices (GDP). Good ... ensures that products are consistently stored, transported and handled ... (MA) or product specification. Only a few years ago, ...
(Date:5/4/2016)... 2016 Research and ... Actinic Keratosis Market and Competitive Landscape Highlights ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ) ... Landscape Highlights 2016, provides comprehensive insights into ... Actinic Keratosis market valuations and forecast, Actinic ...
Breaking Medicine Technology: